Neuroprotective Evaluation of N-Benzyl-2-[4-(Aryl)-1H-1,2, 3-Triazol-1-Yl]ethan-1-Imine Oxides
Acta Poloniae Pharmaceutica - Drug Research · 03.03.2026 · 82 (5) · 783-788
DOI: 10.32383/appdr/216268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 03.03.2026. Verfasst von Raquel L Arribas und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Despite the undeniable achievements of medicinal chemistry in the search for new compounds with neuroprotective activity, there is currently no approved effective drug with a promising profile to effectively treat neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, among others. Four representative N-benzyl-2-[4-(aryl)-1H-1,2,3-triazol-1-yl]ethan-1-imine oxides, which have already been shown to be good antioxidants, were selected to evaluate their neuroprotective potency. N-Benzyl-2-[4-(4-fluorophenyl)-1H-1,2,3-triazol-1-yl]ethan-1-imine oxide (2) exhibited strong antioxidant effects comparable to melatonin, however, the lack of efficacy in reversing okadaic acid-induced toxicity highlights the need for further structural optimization to broaden its neuroprotective spectrum.
Zitieren
APA
Arribas, R. L., Rios, C. D. L., Głowacka, I. E., Marco-Contelles, J. L., & Piotrowska, D. G. (2026). Neuroprotective Evaluation of N-Benzyl-2-[4-(Aryl)-1H-1,2, 3-Triazol-1-Yl]ethan-1-Imine Oxides. Acta Poloniae Pharmaceutica - Drug Research, 82(5), 783-788. https://doi.org/10.32383/appdr/216268
Vancouver
Arribas RL, Rios CDL, Głowacka IE, Marco-Contelles JL, Piotrowska DG. Neuroprotective Evaluation of N-Benzyl-2-[4-(Aryl)-1H-1,2, 3-Triazol-1-Yl]ethan-1-Imine Oxides. Acta Poloniae Pharmaceutica - Drug Research. 2026;82(5):783-788. doi:10.32383/appdr/216268
BibTeX
@article{Arribas2026,
author = {Arribas, Raquel L and Rios, Cristobal De Los and Głowacka, Iwona E. and Marco-Contelles, Jose L and Piotrowska, Dorota G.},
title = {Neuroprotective Evaluation of N-Benzyl-2-[4-(Aryl)-1H-1,2, 3-Triazol-1-Yl]ethan-1-Imine Oxides},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2026},
volume = {82},
number = {5},
pages = {783--788},
doi = {10.32383/appdr/216268}
}
EUVIMED